SEATTLE--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) announced today that Clay B. Siegall, Ph.D., President and Chief Executive Officer, will participate in a panel discussion entitled “Cancer Antibodies: Developing A Pipeline” on Wednesday, December 13, 2006, at 11:00 a.m. Eastern Time as part of the 2006 RBC Capital Markets Healthcare Conference being held at the Westin New York at Times Square Hotel in New York City. The panel will be moderated by Jason Kantor, Ph.D., Biotechnology Equity Research Analyst at RBC Capital Markets.
